The landscape of managing diabetes is advancing with the emergence of skin-applied GLP-1 therapy. These novel patches offer a likely simpler alternative to injections for individuals dealing with type 2 diabetes . They deliver a GLP-1 agonist directly through the dermis , circumventing the necess